1. Introduction {#s0005}
===============

Several studies carried out in Western countries have established that endothelial dysfunction, triggered by various cardiovascular risk factors, is the primum movens of the arterial remodelling process leading to atherosclerosis and then atherothrombotic events \[[@bb0005],[@bb0010]\]. In sub-Saharan Africa, data on prevalence, risk factors and pathobiology of carotid atherosclerosis are scarce. To address this knowledge gap, we have conducted several prospective studies in Malawi, a country with \>10% prevalence of HIV \[[@bb0015], [@bb0020], [@bb0025], [@bb0030]\]. In one study, we showed that endothelial dysfunction persists despite antiretroviral therapy and could, therefore, contribute to the development of atherosclerosis \[[@bb0025]\]. In a subsequent study, we reported a 39.4% prevalence of carotid atherosclerosis in a sample of 66 patients presenting with an acute stroke-like syndrome \[[@bb0035]\]. Plasma samples were also collected from the patients to investigate the relationship between biomarkers of endothelial dysfunction and carotid atherosclerosis. Here, we present and discuss the findings of these complimentary analyses.

2. Methods {#s0010}
==========

2.1. Selection of patients and ultrasound assessment {#s0015}
----------------------------------------------------

Participants were recruited consecutively from April to August 2017 at the Queen Elizabeth Central Hospital which is the largest referral hospital in Malawi. The presence of any cardiovascular risk factor was recorded according to previously reported definitions \[[@bb0035]\].

Carotid ultrasound examination was performed on the day of enrolment (JKT) using the CX50 portable ultrasound device (Philips, Amsterdam, NL). Details of the examination protocol and criteria for the interpretation of findings were reported previously \[[@bb0035]\]. Briefly, the examination comprised a semi-automated assessment of the carotid intima-media thickness (cIMT) and a grading of any existing stenosis. Carotid atherosclerosis was defined as abnormal intima-media thickness or presence of carotid plaque with or without stenosis.

In order to define abnormal cIMT, the following age-specific cut-offs were applied: 0.60 mm (30--39 years old), 0.65 mm (40--49 years old), 0.70 mm (50--59 years old), 0.75 mm (60--69 years old), and 0.80 mm (≥70 years old). In the absence of reference values specific to African populations, the reference cut-off in each age category was chosen close to the upper limit of the 95% confidence interval of the mean cIMT for participants without cardiovascular risk factors enrolled in the PARC study (Paroi Artérielle et Risque Cardiovasculaire) \[[@bb0040]\]. Results of the PARC study suggest that the normal aging of the arterial vessel wall is associated with intima-media thickening by approximately 0.5 mm per decade. In patients with cardiovascular risk factors, the cIMT is typically higher that the indicated cut-off in each age category and is dependent on the number of cardiovascular risk factors as illustrated in the Mannheim consensus guidelines \[[@bb0045]\].

2.2. Measurement of biomarkers of endothelial dysfunction {#s0020}
---------------------------------------------------------

We used ELISA kits from Abcam ® (Abcam plc, Cambridge, United Kingdom) to measure the plasma concentrations of biomarkers of endothelial activation (intercellular adhesion molecule, ICAM-1), endothelial damage (plasminogen activator inhibitor 1, PAI-1), angiogenesis (vascular endothelial growth factor, VEGF), and coagulopathy (soluble thrombomodulin, sTM). SimpleStep® ELISA kits were used for ICAM-1, PAI-1, and sTM while the standard kit was used for VEGF. All samples were run in duplicates and samples with an individual coefficient of variability (CV) greater than 25% were retested in duplicates.

All the ELISA tests were performed according to the manufacturer's instructions with exception of the washing steps that were performed with an automated washer (ASYS Atlantis®, Biochrom Ltd., Cambridge, UK) using a mixture of phosphate buffer saline and Tween 20 (0.05% *v*/v). The plates were read at 450 nm using an automated microplate reader (EZ Read®, Biochrom Ltd., Cambridge, UK). The standard curves were built using 4-parameter logistic regression. The mean intra-assay CV for ICAM-1, PAI-1, VEGF, and sTM was 3.3%, 3.2%, 8.0%, and 3.1% respectively (accepted value \<10%). The mean inter-assay CV for ICAM-1, PAI-1, VEGF, and sTM was 4.1%, 4.1%, 9.0%, and 2.8% respectively (accepted value \<15%).

2.3. Statistical analysis {#s0025}
-------------------------

Participants\' demographic and clinical parameters were summarized as proportions and means with 95% confidence interval for categorical and numerical variables, respectively. The relationship between plasma levels of biomarkers of endothelial dysfunction and cIMT was explored using the Spearman rank correlation test.

A univariable logistic regression analysis was performed to study the relationship between carotid atherosclerosis (dependent variable) and various demographic and clinical parameters of the participants. Following the approach in our previous publications \[[@bb0025],[@bb0030]\], age was dichotomized at 45 years while biomarkers were dichotomized at the third tertile of the distribution of plasma concentration values (low versus high level). A multivariable analysis was not performed due to the small sample size. All statistical tests were two-tailed and statistical significance was defined as *p* ≤ .05. Analyses were performed using the software STATA (version 13, StataCorp, College Station, TX, USA).

3. Results {#s0030}
==========

The mean age of the participants was 58.7 years (95% CI: 54.4--63.1). There were 22 HIV-positive patients and 77.3% were on antiretroviral therapy. HIV+ cases were younger (mean age 43.6 versus 66.3, *p* \< .001) and their mean CD4+ T cell count was 223/mm^3^. There was no difference in the levels of biomarkers between HIV-positive and HIV-negative patients. The baseline characteristics of the participants are summarized in [Table 1](#t0005){ref-type="table"}.Table 1Participants\' baseline characteristics.Table 1Characteristics[a](#tf0005){ref-type="table-fn"}Carotid atherosclerosisYes (*n* = 26)No (*n* = 40)Age (years)63.0 (57.7--68.2)56.1 (49.7--62.4)Age \> 45 years25 (96.2)27 (67.5)Men13 (50.0)15 (37.5)HIV positive7 (27.0)15 (37.5)On ART7 (26.9)10 (25.0)Smoking3 (11.5)5 (12.5)Alcohol consumption4 (15.4)9 (22.5)Hypercholesterolemia3 (11.5)0 (0.0)Hypertension21 (80.8)21 (52.5)Diabetes mellitus5 (19.2)6 (15.0)Waist-hip ratio0.9 (0.9--1.0)0.9 (0.8--0.9)CD4+ count472.3 (377.7--566.9)421.2 (320.2--522.2)ICAM-1 (ng/mL)377.4 (244.2--510.6)404.7 (268.4--540.9)PAI-1 (ng/mL)43.0 (26.8--59.2)49.3 (31.0--67.5)sTM (ng/mL)8.1 (5.6--10.6)6.2 (5.1--7.4)VEGF (pg/mL)12.8 (0.0--26.7)4.4 (0.9--8.0)[^1]

There was no correlation between the plasma concentration of the biomarkers of endothelial dysfunction and the value of cIMT (Spearman rank correlation coefficient of −0.24, −0.03, 0.11, 0.11 for ICAM-1, PAI-1, sTM, and VEGF, respectively).

In the univariable logistic regression ([Table 2](#t0010){ref-type="table"}), the following factors were associated with carotid atherosclerosis: age \> 45 years (OR = 12.0, 95% CI: 1.4--98.8, *p* = .02), hypertension (OR = 3.8, 95% CI: 1.2--12.1, p = .02), and high-level of soluble thrombomodulin (OR = 3.4, 95% CI: 1.2--10.0, p = .02).Table 2Univariable analysis of factors associated with carotid atherosclerosis.Table 2Characteristic[a](#tf0010){ref-type="table-fn"}Univariable analysisOR95% CIpHIV infection0.60.2--1.80.38Age \> 4512.01.4--98.80.02Male1.60.6--4.50.32Hypertension3.81.2--12.10.02Diabetes mellitus1.30.4--5.00.65Smoking0.90.2--4.20.91Waist-hip ratio (*3rd tertile)*1.90.7--5.50.22ART started1.10.4--3.40.86High level of ICAM-10.80.3--2.40.72High level of PAI-11.10.4--3.10.86High level of sTM3.41.2--10.00.02High level of VEGF1.80.6--5.50.32[^2]

4. Discussion {#s0035}
=============

This study is the first to investigate the relationship between biomarkers of endothelial dysfunction and carotid atherosclerosis in sub-Saharan Africa. The association between high levels of soluble thrombomodulin and carotid atherosclerosis is in line with findings in Western populations \[[@bb0050],[@bb0055]\]. Soluble thrombomodulin is an endothelial membrane glycoprotein also known as CD141. It is a marker of endothelial injury and higher plasma levels have been associated with other risk factors of atherosclerosis, notably age and hypertension \[[@bb0060]\]. In this study, patients with carotid atherosclerosis had a higher mean age and a higher prevalence of hypertension, which could contribute to the association between high levels of soluble thrombomodulin and carotid atherosclerosis. Due to the small sample size of this exploratory study, we could not reliably assess the independence of the association in a multivariable analysis. Further studies with a larger sample size are, therefore, needed to confirm our findings in African populations and investigate the performance of biomarkers of endothelial dysfunction as predictors of cardiovascular events. The small sample size likely also explains why our analysis did not show an association between carotid atherosclerosis and other established drivers of endothelial dysfunction and atherosclerosis, notably smoking, diabetes mellitus, adiposity, and HIV infection \[[@bb0065], [@bb0070], [@bb0075], [@bb0080]\]. Specifically, for HIV-positive patients who are younger, longitudinal studies are needed to investigate if the persistence of HIV-induced endothelial dysfunction has a significant and independent impact on the incidence of carotid atherosclerosis and whether antiretroviral or anti-inflammatory drugs are useful to prevent its progression and cerebrovascular consequences. Such studies should ideally be performed on large sample size populations and follow international consensus recommendations for the assessment of subclinical and clinical atherosclerosis in order to avoid generating more heterogeneous or contradictory results \[[@bb0085]\].
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[^1]: Data are presented as N (%) or mean (95%CI).

[^2]: There were 3 patients with hypercholesterolemia and they all had carotid atherosclerosis.
